JP2008516614A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008516614A5 JP2008516614A5 JP2007537041A JP2007537041A JP2008516614A5 JP 2008516614 A5 JP2008516614 A5 JP 2008516614A5 JP 2007537041 A JP2007537041 A JP 2007537041A JP 2007537041 A JP2007537041 A JP 2007537041A JP 2008516614 A5 JP2008516614 A5 JP 2008516614A5
- Authority
- JP
- Japan
- Prior art keywords
- listeria
- culture
- medium
- bioreactor
- vessel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62013304P | 2004-10-18 | 2004-10-18 | |
| PCT/US2005/038237 WO2006045110A2 (en) | 2004-10-18 | 2005-10-18 | High cell density process for growth of listeria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008516614A JP2008516614A (ja) | 2008-05-22 |
| JP2008516614A5 true JP2008516614A5 (cg-RX-API-DMAC7.html) | 2008-12-04 |
Family
ID=36203744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007537041A Abandoned JP2008516614A (ja) | 2004-10-18 | 2005-10-18 | リステリア増殖のための高細胞密度法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060121053A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1802338A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008516614A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005295158A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2584130A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006045110A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8956621B2 (en) | 1994-11-08 | 2015-02-17 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of cervical dysplasia |
| US7820180B2 (en) * | 2004-09-24 | 2010-10-26 | The Trustees Of The University Of Pennsylvania | Listeria-based and LLO-based vaccines |
| US7662396B2 (en) * | 2001-03-26 | 2010-02-16 | The Trustees Of The University Of Pennsylvania | Compositions and methods for enhancing the immunogenicity of antigens |
| US8791237B2 (en) * | 1994-11-08 | 2014-07-29 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of non-hodgkins lymphoma |
| US7794729B2 (en) * | 1994-11-08 | 2010-09-14 | The Trustees Of The University Of Pennsylvania | Methods and compositions for immunotherapy of cancer |
| US8114414B2 (en) | 1994-11-08 | 2012-02-14 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of cervical cancer |
| US6051237A (en) * | 1994-11-08 | 2000-04-18 | The Trustees Of The University Of Pennsylvania | Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| US9012141B2 (en) | 2000-03-27 | 2015-04-21 | Advaxis, Inc. | Compositions and methods comprising KLK3 of FOLH1 antigen |
| JP2004500405A (ja) * | 2000-03-29 | 2004-01-08 | ザ トラスティーズ オブ ザ ユニバーシティー オブ ペンシルヴァニア | 抗原の免疫原性を増強するための組成物および方法 |
| US7700344B2 (en) * | 2001-03-26 | 2010-04-20 | The Trustees Of The University Of Pennsylvania | Compositions and methods for enhancing the immunogenicity of antigens |
| US8771702B2 (en) | 2001-03-26 | 2014-07-08 | The Trustees Of The University Of Pennsylvania | Non-hemolytic LLO fusion proteins and methods of utilizing same |
| US7842289B2 (en) | 2003-12-24 | 2010-11-30 | Aduro Biotech | Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
| WO2007061848A2 (en) * | 2005-11-17 | 2007-05-31 | The Trustees Of The University Of Pennsylvania | Methods for producing, growing, and preserving listeria vaccine vectors |
| EP2056849A4 (en) * | 2006-08-04 | 2010-09-08 | Univ Pennsylvania | METHOD AND COMPOSITIONS FOR TREATING IGE-MEDIATED ILLNESSES |
| US8241636B2 (en) * | 2006-08-15 | 2012-08-14 | The Trustees Of The University Of Pennsylvania | Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof |
| US8268326B2 (en) * | 2006-08-15 | 2012-09-18 | The Trustees Of The University Of Pennsylvania | Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof |
| JP5757863B2 (ja) | 2008-05-19 | 2015-08-05 | アドバクシス インコーポレイテッド | 異種抗原のための二重送達システム |
| US9017660B2 (en) | 2009-11-11 | 2015-04-28 | Advaxis, Inc. | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors |
| US9650639B2 (en) | 2008-05-19 | 2017-05-16 | Advaxis, Inc. | Dual delivery system for heterologous antigens |
| US8778329B2 (en) | 2009-03-04 | 2014-07-15 | The Trustees Of The University Of Pennsylvania | Compositions comprising angiogenic factors and methods of use thereof |
| US10016617B2 (en) | 2009-11-11 | 2018-07-10 | The Trustees Of The University Of Pennsylvania | Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers |
| AU2011223789A1 (en) | 2010-03-01 | 2012-09-20 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarkers for theranostics |
| KR20130043104A (ko) | 2010-04-06 | 2013-04-29 | 카리스 라이프 사이언스 룩셈부르크 홀딩스 | 질병용 순환 생물학적 지표들 |
| CN107412756A (zh) | 2010-10-01 | 2017-12-01 | 宾夕法尼亚大学理事会 | 李斯特菌疫苗载体用于在寄生虫感染的个体中扭转免疫无应答的用途 |
| CA2829960A1 (en) | 2011-03-11 | 2012-09-20 | John Rothman | Listeria-based adjuvants |
| BR112014022662A2 (pt) | 2012-03-12 | 2017-10-03 | Advaxis Inc | Inibição da função de célula supressora seguindo tratamento de vacina de listeria |
| AU2015250111A1 (en) * | 2014-04-24 | 2016-12-08 | Advaxis, Inc. | Recombinant listeria vaccine strains and methods of producing the same |
| EP3313975A4 (en) * | 2015-06-24 | 2019-03-13 | Advaxis, Inc. | MANUFACTURING DEVICE AND METHOD FOR PERSONALIZED ADMINISTRATION OF VECTOR-BASED IMMUNOTHERAPY |
| US10774390B2 (en) * | 2015-09-02 | 2020-09-15 | The Regents Of The University Of California | Methods and compositions for modulating PrfA mediated virulence gene activation in Listeria spp |
| US20180325964A1 (en) * | 2015-11-20 | 2018-11-15 | Advaxis, Inc. | Manufacturing device and method of an immunotherapeutic formulation comprising a recombinant listeria strain |
| JP7284156B2 (ja) * | 2017-09-19 | 2023-05-30 | アドバクシス, インコーポレイテッド | 細菌またはListeria株の凍結乾燥のための組成物および方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6051237A (en) * | 1994-11-08 | 2000-04-18 | The Trustees Of The University Of Pennsylvania | Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| US6927203B1 (en) * | 1999-08-17 | 2005-08-09 | Purdue Research Foundation | Treatment of metastatic disease |
| US7425449B2 (en) * | 2002-04-30 | 2008-09-16 | The Regents Of The University Of California | Site specific Listeria integration vectors and methods for using the same |
| US20050152899A1 (en) * | 2002-05-10 | 2005-07-14 | Kinch Michael S. | EphA2 agonistic monoclonal antibodies and methods of use thereof |
| EP1519956B1 (en) * | 2002-05-10 | 2011-09-21 | Medimmune, Inc. | Epha2 monoclonal antibodies and methods of use thereof |
| EP1575509B1 (en) * | 2002-05-10 | 2011-10-26 | Purdue Research Foundation | Epha2 agonistic monoclonal antibodies and methods of use thereof |
| JP2006507256A (ja) * | 2002-09-24 | 2006-03-02 | ザ バーナム インスティチュート | Eph受容体活性を調節する新規薬剤 |
| ATE552843T1 (de) * | 2003-02-06 | 2012-04-15 | Aduro Biotech | Listerien deren eindringen in nicht-phagozytische zellen abgeschwächt ist, impfstoffe, die diese listerien enthalten und deren verwendungen |
| EP1618184A4 (en) * | 2003-04-11 | 2006-06-21 | Medimmune Inc | EPHA2, HYPOPROLIFERATIVE CELL DISORDERS, AND EPITHELIAL AND ENDOTHELIAL RECONSTITUTION |
| EP1617864A4 (en) * | 2003-04-11 | 2006-06-21 | Medimmune Inc | EPHA2 AND NON-NEOPLASTIC HYPERPROLIFERATIVE CELL TROUBLESHOOTING |
| US20050147593A1 (en) * | 2003-05-22 | 2005-07-07 | Medimmune, Inc. | EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders |
| CA2533789C (en) * | 2003-07-30 | 2013-09-17 | University Of Pittsburgh Of The Commnonwealth System Of Higher Education | Epha2 t-cell epitope agonists and uses therefor |
| EP1660186B1 (en) * | 2003-08-18 | 2013-12-25 | MedImmune, LLC | Humanization of antibodies |
| US20050042664A1 (en) * | 2003-08-22 | 2005-02-24 | Medimmune, Inc. | Humanization of antibodies |
| KR20060130038A (ko) * | 2003-10-15 | 2006-12-18 | 메디뮨 인코포레이티드 | 리스테리아에 의거한 EphA2 백신 |
| US20050153923A1 (en) * | 2003-12-04 | 2005-07-14 | Kinch Michael S. | Targeted drug delivery using EphA2 or EphA4 binding moieties |
| EP1773391A4 (en) * | 2004-06-25 | 2009-01-21 | Medimmune Inc | INCREASING THE PRODUCTION OF RECOMBINANT ANTIBODIES IN MAMMALIAN CELLS BY MUTAGENESIS ON THE SITE |
| AU2005277641A1 (en) * | 2004-08-16 | 2006-03-02 | Medimmune, Llc | Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
| EP1812077A4 (en) * | 2004-10-27 | 2009-12-02 | Medimmune Inc | MODULATORS OF EPHA2 AND EPHRINA1 FOR TREATING A FIBROSIS-ASSOCIATED DISEASE |
| WO2006047639A2 (en) * | 2004-10-27 | 2006-05-04 | Medimmune, Inc. | Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| US20060121043A1 (en) * | 2004-10-27 | 2006-06-08 | Medimmune, Inc. | Use of modulators of EphA2 and EphrinA1 for the treatment and prevention of infections |
| EP1809583A2 (en) * | 2004-11-01 | 2007-07-25 | MedImmune, Inc. | Ultra high throughput capture lift screening methods |
| WO2006081418A2 (en) * | 2005-01-27 | 2006-08-03 | The Burnham Institute | Ephb receptor-binding peptides |
| US20050181479A1 (en) * | 2005-03-04 | 2005-08-18 | Medimmune, Inc. | Periplasmic expression of antibodies using a single signal sequence |
| AU2006304387A1 (en) * | 2005-10-14 | 2007-04-26 | Medimmune, Llc | Cell display of antibody libraries |
-
2005
- 2005-10-18 CA CA002584130A patent/CA2584130A1/en not_active Abandoned
- 2005-10-18 US US11/254,132 patent/US20060121053A1/en not_active Abandoned
- 2005-10-18 AU AU2005295158A patent/AU2005295158A1/en not_active Abandoned
- 2005-10-18 WO PCT/US2005/038237 patent/WO2006045110A2/en not_active Ceased
- 2005-10-18 EP EP05812104A patent/EP1802338A4/en not_active Withdrawn
- 2005-10-18 JP JP2007537041A patent/JP2008516614A/ja not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006045110A3 (en) | High cell density process for growth of listeria | |
| JP2023511430A (ja) | 微生物由来蛋白質加水分解物、ならびにその調製法およびその用途 | |
| CA1262694A (en) | Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria | |
| ES2573980T3 (es) | Materiales y métodos para la producción eficaz de ácido láctico | |
| CN1276016A (zh) | 低pH乳酸发酵 | |
| JP2016105737A5 (cg-RX-API-DMAC7.html) | ||
| AU2019288208B2 (en) | Methods for producing rich cell culture media using chemoautotrophic microbes | |
| CN108410788A (zh) | 高密度培养大肠杆菌细胞的方法 | |
| JP2021529527A5 (cg-RX-API-DMAC7.html) | ||
| CN111100835A (zh) | Pet降解生物催化剂及其应用 | |
| CN119080916A (zh) | 一种重组人源ⅱ型胶原蛋白、核酸分子、载体、细胞、组合物及其应用 | |
| KR20160145676A (ko) | 고 세포 밀도의 유입 및 배출 발효 공정 | |
| JP2022521235A5 (cg-RX-API-DMAC7.html) | ||
| CN107974432B (zh) | 高效分泌表达猪瘟e2蛋白的cho细胞株的培养方法及其应用 | |
| Richard et al. | C1-proteins prospect for production of industrial proteins and protein-based materials from methane | |
| CN114144511A (zh) | 用于厌氧细菌发酵的方法和组合物 | |
| CN1163608C (zh) | 原核分泌型表达载体及用途 | |
| CN108998463A (zh) | 一种人源胰岛素生长因子-1(igf-1)复合物的制备工艺 | |
| RU2427645C1 (ru) | СПОСОБ МИКРОБИОЛОГИЧЕСКОГО СИНТЕЗА ЗРЕЛОГО ИНТЕРФЕРОНА АЛЬФА-2 ЧЕЛОВЕКА, ШТАММ Saccharomyces cerevisiae - ПРОДУЦЕНТ ЗРЕЛОГО ИНТЕРФЕРОНА АЛЬФА-2 ЧЕЛОВЕКА (ВАРИАНТЫ) | |
| US20120258502A1 (en) | Method of producing recombinant plasmid dna using substantially solid growth medium | |
| CN115747268A (zh) | D-泛酸的发酵方法 | |
| CN1065292A (zh) | 大量制备戊二酰酰基转移酶的方法 | |
| CN105747136B (zh) | 一种鱼类下脚料的骨肉分离方法 | |
| CN86102977A (zh) | 蛋白质的生产 | |
| CN1810954A (zh) | 一种利用大肠杆菌生产人α防御素1蛋白的方法 |